Indian Pharmaceutical Companies Must Meet New Manufacturing Standards Amid International Drug Safety Concerns
Mumbai, India – Indian pharmaceutical companies are facing new manufacturing standards this year, as the central government looks to tighten regulations in the wake of overseas deaths linked to Indian-made drugs. The $50 billion industry has come under scrutiny, prompting the government to take action to clean up its image. A central government notification released on Saturday outlines the new requirements for pharmaceutical factories. The notification emphasizes the manufacturer’s responsibility for ensuring the quality and …